HopeStage
Back to all studies
RecruitingNCT07206212

A lifestyle intervention to reduce cardiometabolic risk factors in individuals with OCD

Research studyAges 18–100Sweden
The study in practice

Understand this study

Who could participate?

This study is for people with OCD. Listed age limits: 18 years to 100 years. Other eligibility criteria apply.

Listed locations
HuddingeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 30, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Psychiatry Southwest [Psykiatri Sydväst], Stockholm Healthcare Services [Stockholms läns sjukvårdsområde (SLSO)], Region Stockholm
Sponsor type
Unknown or unclear
Study type
Other
Intervention type
Other / unclear
Locations
Sweden
Age range
From 18 Years to 100 Years
Official registry ID
NCT07206212
Official title
Show the full official title

Efficacy and Cost-effectiveness of a Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder: A Randomized Controlled Trial

Recruitment & locations

Currently recruiting

Huddinge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Psychiatry Southwest [Psykiatri Sydväst], Stockholm Healthcare Services [Stockholms läns sjukvårdsområde (SLSO)], Region Stockholm.

Who can participate?

This study is for people with OCD. Listed age limits: 18 years to 100 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies